Cytokinetics, Inc. (CYTK)
61.61
-2.52
(-3.93%)
USD |
NASDAQ |
Dec 09, 15:55
Cytokinetics EPS Diluted (Quarterly): -2.552 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jasper Therapeutics, Inc. | -1.126 |
| Lantheus Holdings, Inc. | 0.4104 |
| Bristol Myers Squibb Co. | 1.079 |
| Pfizer Inc. | 0.6197 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -306.18M |
| Revenue (Quarterly) | 1.936M |
| Total Expenses (Quarterly) | 308.11M |
| Enterprise Value | 8.072B |
| Gross Profit Margin (Quarterly) | -38.38% |
| Profit Margin (Quarterly) | -15.81K% |
| Earnings Yield | -10.24% |
| Normalized Earnings Yield | -8.963 |